This site is for customers in Asia. Customers in China & other regions, please go to Global page.
HOME > Product category > Fluorescent proteins > Fluoppi

Fluoppi


Image based Protein-Protein interaction (PPI) analysis

  • Detect PPI as fluorescent " Foci " in living cells
  • " Reversible " foci-formation
  • " Easy -to-handle"

What is Fluoppi?

list

PPI induction PPI inhibition


mTOR(FRB) and FKBP12 p53 and MDM2

>> watch the videos in large size

Fluoppi (Fluorescent based technology detecting Protein-Protein Interactions) is a novel technology to detect Protein-Protein Interaction (PPI) in living cells. Fluoppi detects PPI as fluorescent foci in reversible manner. The most important advantage of Fluoppi is that construction of the PPI detection system is very easy and does not need fine optimizations such like a linker sequence or length.


How Fluoppi works ?


Key components

Fluoppi is a tag technology. Tetramer fluorescent protein (FP-tag) and Assembly helper tag (Ash-tag) are genetically fused to Protein X and Y, respectively. For the FP-tag, tetramer Green Fluorescent protein Azami Green (hAG) can be used. For the Ash-tag, PB1 domain of p62 can be used. PB1 is 102 amino acid length domain which has the capability of electrostatically homo-oligomerization in a head to tail manner (Saio et al. 2010). In our in vitro Fluorescence correlation spectroscopy analysis, Ash-tag behaved as tetramer to octomer in diluted solution.


Mechanism of action

Before protein X and Y interact, most of the molecule is disseminated.
When protein X and Y interact, these proteins associate each other to form detectable foci.


Product format

Fluoppi tags are able to work in both N and C terminal fusion. We have several plasmid vectors which include CMV promoter, Fluoppi tag, flexible peptide linker, Multiple Cloning Site (MCS) and Neomycin resistant gene.

Fluorescence characteristics


Excit./Emiss.Maxima (nm) Extinction coefficient (M-1cm-1) Fluorescence quantum yield pH sensitivity
AG 492/505 72,300 (492 nm) 0.67 pKa=5.0

Workflow

1. Target gene amplification & restriction enzyme cut

At first, proteins X & Y of your interest are fused to FP-tag and Ash-tag respectively.
We recommend to prepare all the eight possible constructs to identify the best workable combination.


2. Ligation & sequencing


3. Transfection

Co-transfect the pairs of plasmids.


4. imaging

Because fluorescent signal of Fluoppi is very high, conventional fluorescence microscopy can be used to image the cell.

If the proteins interact with each other upon expression, fluorescent foci will be detected. Formation of foci is reversible so that they can be dissociated and the fluorescent signal will spread over the cell by PPI inhibitors, and vice versa by PPI inducer.



An example of p53-MDM2 PPI

An example of p53-MDM2 PPI. (Partial sequence of p53 and MDM2 were used.)
Upper and middle 8 pictures represent 8 possible combinations. Lower 4 panels are results of negative control; hAG tagged protein and only Ash-tag were co-transfected. As shown in the result, Fluorescent patterns were different from combination to combination, so that we recommend to try all the 8 possible combinations to find the optimum combinations.


Properties


Localizations


Because location of foci is not restricted to specific site inside the cell, Fluoppi can detect PPIs at several subcellular localizations such as cytosol, nucleus, and juxtamembrane. The upper pictures represent foci at several subcellular localizations, and the lower pictures are negative controls which express hAG tagged protein and Ash-tag without fusing any proteins. The images of juxtamembrane are taken by Total Internal Reflection Fluorescence Microscopy (TIRFM).


PPI modulator [induction]


>> watch the video

mTOR (FRB domain) and FKBP12 is a well known PPI whose interaction is induced by Rapamycin. The pair of, mTOR(FRB)-hAG and Ash-FKBP12 was selected from eight possible combinations in a viewpoint of foci formation efficiency. After adding Rapamycin small foci were gradually formed in several minutes.



Dose dependent foci formations of Rapamycin (left) or competitive inhibition of Rapamycin by FK506 (right) were analyzed. Cells were treated with Rapamycin for 60 min in 37°C CO2 incubator followed by PFA fixation. Images were captured by ORCA-ER(Hamamatsu photonics) on IX71 fluorescence microscopy (Olympus). The spot detector plugin from ICY platform (Institut Pasteur) and IGOR software (HULINKS Inc.) were used for this analysis.



PPI modulator [inhibition]


>> watch the video

p53-MDM2 is a famous target of PPI inhibitors in the field of anti cancer drug development. We applied this PPI to Fluoppi for demonstration. First, hAG-MDM2 and Ash-p53 was selected from the 8 pairs as represented above, then stable CHO-K1 cell line was established by using two selection marker; G418 and Hygromycin. Fluoppi plasmids including Hygromycin resistance gene is under released at present.


Time course of foci dissociation after adding Nutlin-3 was analyzed. Y axis represents fluorescent intensity of foci.

Dose dependent foci dissociations of Nutlin-3 were analyzed. Cells were treated with Nutlin-3 for 30 min followed by PFA fixation. Images were measured by InCellAnalyzer1000(GE healthcare).


Products

Code no. Product Name DNA sequence
AM-8011M Fluoppi Ver.2 : Ash-hAG (Ash-MNL/MCL + hAG-MNL/MCL) pAsh-MNL Ver.2word, pAsh-MCLword, phAG-MNLword, phAG-MCLword
AM-8012M Fluoppi Ver.2 : Ash-Red (Ash-MNL/MCL + Monti-Red-MNL/MCL) pAsh-MNL Ver.2word, pAsh-MCLword, pMonti-Red-MNL, word, pMonti-Red-MCLword
AM-8201M Fluoppi : Ash-hAG [p53-MDM2] pAsh/p53word, phAG/MDM2word
AM-8202M Fluoppi : Ash-hAG [mTOR-FKBP12] pAsh/FKBP12word, phAG/mTORword
SI-8010 Fluoppi: Ash-hAG-Lenti pCMV (Ash-Neo-MNL/MCL + hAG-Puro-MNL/MCL)
pLV-CMV-Ash-MNL-Neomycinword, pLV-CMV-Ash-MCL-Neomycinword, pLV-CMV-hAG-MNL-Puromycinword, pLV-CMV-hAG-MCL-Puromycinword
SI-8011 Fluoppi: Ash-hAG-Lenti pCMV (Ash-Puro-MNL/MCL + hAG-Neo-MNL/MCL) pLV-CMV-Ash-MNL-Puromycinword, pLV-CMV-Ash-MCL-Puromycinword, pLV-CMV-hAG-MNL-Neomycinword, pLV-CMV-hAG-MCL-Neomycinword
SI-8020 Fluoppi: Ash-hAG-Lenti pEF1a (Ash-Neo-MNL/MCL + hAG-Puro-MNL/MCL) pLV-EF1a-Ash-MNL-Neomycinword, pLV-EF1a-Ash-MCL-Neomycinword, pLV-EF1a-hAG-MNL-Puromycinword, pLV-EF1a-hAG-MCL-Puromycinword
SI-8021 Fluoppi: Ash-hAG-Lenti pEF1a (Ash-Puro-MNL/MCL + hAG-Neo-MNL/MCL) pLV-EF1a-Ash-MNL-Puromycinword, pLV-EF1a-Ash-MCL-Puromycinword, pLV-EF1a-hAG-MNL-Neomycinword, pLV-EF1a-hAG-MCL-Neomycinword

Publications

  • Koyano F, et al., Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 510, 162-166 (2014) [PMID: 24784582]
  • Yamano K, et al., Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation. J Biol Chem. 290, 25199-211 (2015) [PMID: 26260794]

References

  • Saio T, et al., PCS-based structure determination of protein-protein complexes. J. Biomol. NMR. 46, 271-280 (2010) [PMID: 20300805]
  • Banaszynski LA, et al., Characterization of the FKBP.rapamycin.FRB ternary complex. J. Am. Chem. Soc. 127, 4715-21. (2005) [PMID: 15796538]
  • Vassilev LT, et al., In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 303, 844-848. (2004) [PMID: 14704432]








Please send us a completed and signed License Acknowledgement.

Please note that the product will be shipped after we receive a completed and signed License Acknowledgement (PDF file on the right). Prior to shipping, our staff may contact you to verify the intended use of the product. Please also note that a separate agreement or a contract may be required depending on the intended use.
The product you have ordered is sold for research purpose only. It is not intended for industrial or clinical use, and shall not be used for any purposes other than research. You are also asked not to hand over or resell the product to a third party.
If you belong to a profit organization or a business corporation, or wish to use the product for profit or commercial purposes, please contact us.